Team:Goettingen/project overview/perspectives

From 2014.igem.org

(Difference between revisions)
m
m
Line 12: Line 12:
<div class="proLP">
<div class="proLP">
         <h3>Project</h3>
         <h3>Project</h3>
 +
 +
         <ul>
         <ul>
-
         <li><a href="https://2014.igem.org/Team:Goettingen/project_overview">Background</a>
+
         <li>Background
-
        <ul>
+
              <ul>
-
        <li><a href="https://2014.igem.org/Team:Goettingen/project_overview">The global burden of fungal infections</a></li>
+
              <li><a href="https://2014.igem.org/Team:Goettingen/project_overview"><b>The global burden of fungal infections</b></a></li>
-
        <li><a href="https://2014.igem.org/Team:Goettingen/project_overview/fungal_infections">Fungal infections</a></li>
+
              <li><a href="https://2014.igem.org/Team:Goettingen/project_overview/fungal_infections">Fungal infections</a></li>
-
        <li><a href="https://2014.igem.org/Team:Goettingen/project_overview/current_tools">Current diagnostic tools</a></li>
+
              <li><a href="https://2014.igem.org/Team:Goettingen/project_overview/current_tools">Current diagnostic tools</a></li>
-
        </ul>
+
              </ul>
         </li>
         </li>
         <li><a href="https://2014.igem.org/Team:Goettingen/project_overview/project">Our project!</a></li>
         <li><a href="https://2014.igem.org/Team:Goettingen/project_overview/project">Our project!</a></li>
         <li><a href="https://2014.igem.org/Team:Goettingen/project_overview/perspectives">Further perspectives</a>
         <li><a href="https://2014.igem.org/Team:Goettingen/project_overview/perspectives">Further perspectives</a>
-
        <ul>
+
                <ul>
-
        <li><a href="https://2014.igem.org/Team:Goettingen/project_overview/diganosis">Diagnosis</a></li>
+
                <li><a href="https://2014.igem.org/Team:Goettingen/project_overview/diganosis">Diagnosis</a></li>
-
        <li><a href="https://2014.igem.org/Team:Goettingen/project_overview/therapeutics">Therapeutics</a></li>
+
                <li><a href="https://2014.igem.org/Team:Goettingen/project_overview/therapeutics">Therapeutics</a></li>
-
        </ul>
+
                </ul>
         </li>
         </li>
 +
       
 +
 +
       
 +
<li><a href="https://2014.igem.org/Team:Goettingen/project_overview/project_drylab">Dry lab</a></li>
 +
<li><a href="https://2014.igem.org/Team:Goettingen/project_overview/project_wetlab">Wet lab</a></li>
 +
<li><a href="https://2014.igem.org/Team:Goettingen/project_overview/project_gallery">Gallery</a></li>
 +
        <li><a href="https://2014.igem.org/Team:Goettingen/project_overview/project_biobrick">BioBrick</a></li>
         </ul>
         </ul>
 +
         </div>
         </div>
<!-- end of left column-->
<!-- end of left column-->
Line 33: Line 43:
<!-- right column-->
<!-- right column-->
<div class="proRP" id="rpart1">
<div class="proRP" id="rpart1">
-
<div id="goenext"><a href="https://2014.igem.org/Team:Goettingen/project_overview/project"><img src='https://static.igem.org/mediawiki/2014/3/32/Goettingen2014-previous.png' width='50px'></a> 5/7 <a href="https://2014.igem.org/Team:Goettingen/project_overview/diganosis"><img src='https://static.igem.org/mediawiki/2014/e/ea/Goettingen2014-next.png' width='50px'></a></div><br />
+
<div id="goenext"><a href="https://2014.igem.org/Team:Goettingen/project_overview/project"><img src='https://static.igem.org/mediawiki/2014/3/32/Goettingen2014-previous.png' width='50px'></a> 5/11 <a href="https://2014.igem.org/Team:Goettingen/project_overview/diganosis"><img src='https://static.igem.org/mediawiki/2014/e/ea/Goettingen2014-next.png' width='50px'></a></div><br />
       <h1 >Further perspectives</h1><br />
       <h1 >Further perspectives</h1><br />

Revision as of 08:41, 15 September 2014

5/11

Further perspectives


There are two main achievements in our project. First, there is the generation of peptides with affinity towards fungal surface proteins and second, there is the general proof of principle that our selection scheme can be used to generate peptides with affinity to a given protein. Both achievements have promising perspectives, but we'd like to detail more on the future perspectives that we can envision for our first achievement since there are a number of considerations that need to be taken into account.